Yeah, the downside would be the cost of running the program, which would be very small in relation to the value of the capital (which would be going to charity, so just subject to normal business risks).
If you see differences in post-acquisition performance, they can expand the fund and other philanthropists will have the incentive to copycat. If the thesis is generally proven, lenders will have the incentive to finance further acquisitions (leveraged buyouts); the sky, or most of the entire economy (other than perhaps startups where equity incentives might outweigh COA advantages), is the limit.
Yeah, the downside would be the cost of running the program, which would be very small in relation to the value of the capital (which would be going to charity, so just subject to normal business risks).
If you see differences in post-acquisition performance, they can expand the fund and other philanthropists will have the incentive to copycat. If the thesis is generally proven, lenders will have the incentive to finance further acquisitions (leveraged buyouts); the sky, or most of the entire economy (other than perhaps startups where equity incentives might outweigh COA advantages), is the limit.
Truly absurd that this is not being explored.